Skip to main content
. 2023 Mar 8;72(Suppl 1):28–35. doi: 10.1007/s00101-023-01264-6

Table 3.

Results of ultrasonographic measurements in control group and nitroglycerin group

Control
(N = 47)
Nitroglycerin
(N = 47)
p-value
Radial artery diameter (cm) < 0.001
T1 0.24 ± 0.04 0.24 ± 0.04
T2 0.24 ± 0.03 0.28 ± 0.04
T3 0.18 ± 0.04 0.24 ± 0.04
Percentage change of radial artery diameter at T2 (%) 0 (0–0) 20 (14–25) < 0.001
Percentage change of radial artery diameter at T3 (%) −30 (−20–−13) 0 (0–9) < 0.001
CSA (cm2) < 0.001
T1 0.045 ± 0.014 0.046 ± 0.012
T2 0.045 ± 0.013 0.066 ± 0.014
T3 0.027 ± 0.011 0.047 ± 0.014
Percentage change of CSA at T2 (%) 0 (0–0) 43(33–60) < 0.001
Percentage change of CSA at T3 (%) −33 (−50–−25) 0 (0–20) < 0.001
Depth (cm) 0.289
T1 0.24 ± 0.03 0.24 ± 0.04
T2 0.30 ± 0.03 0.29 ± 0.04
T3 0.30 ± 0.04 0.28 ± 0.04
TAMAX (cm/s)
T1 22 ± 9 25 ± 7 0.062
T2 22 ± 9 25 ± 6 0.157
Volume of blood flow(ml/sec)
T1 1.04 ± 0.76 1.14 ± 0.47 0.447
T2 1.07 ± 0.69 1.61 ± 0.52 < 0.001

Values are mean ± SD, median (interquartile range) [range]. T1 = baseline; T2 = 3 min after subcutaneous nitroglycerin injection or saline injection; T3 = immediately after radial artery cannulation. CSA cross-sectional area, TAMAX time average maximal velocity